Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells?

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1573-7217
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells? ; volume:136 ; number:3 ; day:27 ; month:10 ; year:2012 ; pages:693-703 ; date:12.2012
Breast cancer research and treatment ; 136, Heft 3 (27.10.2012), 693-703, 12.2012

Creator
Sadanandam, Anguraj
Lal, Aseem
Benz, Stephen C.
Eppenberger-Castori, Serenella
Scott, Gary
Gray, Joe W.
Spellman, Paul
Waldman, Fred
Benz, Christopher C.
Contributor
SpringerLink (Online service)

DOI
10.1007/s10549-012-2290-3
URN
urn:nbn:de:101:1-2019101005581025364667
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Sadanandam, Anguraj
  • Lal, Aseem
  • Benz, Stephen C.
  • Eppenberger-Castori, Serenella
  • Scott, Gary
  • Gray, Joe W.
  • Spellman, Paul
  • Waldman, Fred
  • Benz, Christopher C.
  • SpringerLink (Online service)

Other Objects (12)

Genome profiling of ERBB2-amplified breast cancers

Genome profiling of ERBB2-amplified breast cancers

Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer

Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer

Transcriptome and genome evolution during HER2-amplified breast neoplasia

Transcriptome and genome evolution during HER2-amplified breast neoplasia

Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer

Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers

Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer

Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer

Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial

Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial

Her2/EGFR-PDGFR pathway aberrations associated with tamoxifen response in metastatic breast cancer patients

Her2/EGFR-PDGFR pathway aberrations associated with tamoxifen response in metastatic breast cancer patients

Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer

Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer

Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer

Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer

Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers

Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers

Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers

Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers

Related objects